Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia

Ahmed Alghamdi, Bander Balkhi, Abdulaziz Altowaijri, Nasser Alshehri, Lewis Ralph, Emily-Ruth Marriott, Michael Urbich, Fawaz Aljanad, Rima Aziziyeh

PharmacoEconomics - Open · 2021 · 12 citations · 42 references

DOIFull text

Open access

References

42